Trading Day Review: Amneal Pharmaceuticals Inc (AMRX) Loses Momentum, Closing at 7.81

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $7.81 in the last session, down -0.64% from day before closing price of $7.86. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 2.06 million shares were traded. AMRX stock price reached its highest trading level at $7.93 during the session, while it also had its lowest trading level at $7.665.

Ratios:

We take a closer look at AMRX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 48.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.71. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.33.

On March 08, 2021, Goldman Upgraded its rating to Buy which previously was Sell and also upped its target price recommendation from $4 to $6.50.

Guggenheim Upgraded its Neutral to Buy on December 14, 2020, while the target price for the stock was maintained at $5.50.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 14 ’24 when BOYER ANDREW S bought 70,000 shares for $7.80 per share.

Shah Nikita bought 70,000 shares of AMRX for $550,200 on Aug 14 ’24. On Aug 14 ’24, another insider, Shah Nikita, who serves as the Officer of the company, bought 30,000 shares for $7.86 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 2417530880 and an Enterprise Value of 5164326912. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.93. Its current Enterprise Value per Revenue stands at 1.988 whereas that against EBITDA is 8.96.

Stock Price History:

Over the past 52 weeks, AMRX has reached a high of $8.15, while it has fallen to a 52-week low of $3.36. The 50-Day Moving Average of the stock is 11.42%, while the 200-Day Moving Average is calculated to be 32.70%.

Shares Statistics:

According to the various share statistics, AMRX traded on average about 1.45M shares per day over the past 3-months and 1764250 shares per day over the past 10 days. A total of 306.56M shares are outstanding, with a floating share count of 119.14M. Insiders hold about 61.51% of the company’s shares, while institutions hold 30.26% stake in the company. Shares short for AMRX as of 1722384000 were 4440971 with a Short Ratio of 3.06, compared to 1719532800 on 4520585. Therefore, it implies a Short% of Shares Outstanding of 4440971 and a Short% of Float of 1.72.

Most Popular